-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-004 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-004 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-004 in Solid Tumor Drug Details: NB-004 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-001 in DiGeorge Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-001 in DiGeorge Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-001 in DiGeorge Syndrome Drug Details: Fasoracetam monohydrate is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-003 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-003 in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-003 in Metastatic Melanoma Drug Details: NB-003 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-004 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-004 in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-001 in DiGeorge Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-001 in DiGeorge Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-001 in DiGeorge Syndrome Drug Details: Fasoracetam monohydrate is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nelivaptan in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nelivaptan in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nelivaptan in Major Depressive Disorder Drug Details: Nelivaptan (NB-415, SSR-149415) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-4746 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-4746 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NB-4746 in Amyotrophic Lateral Sclerosis Drug Details: Small molecules are under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-003 in Gastrointestinal Stromal Tumor (GIST)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-003 in Gastrointestinal Stromal Tumor (GIST) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-003 in Gastrointestinal Stromal Tumor (GIST) Drug Details: NB-003 is...
-
Sector Analysis
NewEurope Fibercos and Towercos Market Dynamics and Opportunities
Europe Fibercos and Towercos Market Report Overview Fibercos and towercos in Europe are heading toward organic growth strategies for controlling debts and sustaining rollout targets. Furthermore, infrastructure companies are trying to reduce their carbon emissions by generating power to support their operations. Large consumer base and favorable regulatory environment in Europe have made the region the most viable choice for investments from international telecommunications players. Additionally, a surge in demand for high-speed connectivity in the European economies is encouraging telecom...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Onureg in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onureg in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onureg in Mantle Cell Lymphoma Drug Details: Azacitidine (Onureg) is a...